OrganoGold Nature’s Healing Gift

OrganoGold is a brand of single-serving coffees, teas, and chocolate, made with ganoderma, which is an ancient medicinal mushroom, also known as Reishi, from Japan and China. It is known to the Chinese as spirit medicine. It is believed to promote long life; ganoderma is also a health tonic and preventative. Since the 1970s, it has been in the public awareness and studied scientifically. Although it is now being rediscovered by the Western World as a prized edible mushroom, it has been in use for thousands of years in Asia.

Ganoderma is credited, by WebMD, for boosting the immune system, and for aiding in the treatment of lung diseases, heart diseases, viral infections, kidney disease, flu, cancer, liver problems, HIV, plus a multitude of secondary illnesses. Two of the problems to watch for with this supplement are bleeding disorders and liver reaction; ganderma reacts badly with high blood pressure medications, or with medications that slow blood clotting.

CEO and Founder Bernardo Chua launched OrganoGold in 2008 in British Columbia, and the company is still headquartered there. OG is now sold in 44 countries, and on 6 continents. OrganoGold’s mission is “to bring the treasures of the earth to the people of the world” by offering ganoderma in simple everyday products, like a cup of coffee. OG has attracted some big names to its cause, Manny Pacquiao, renowned boxer, is a supporter. Greg Norman, golfer, is OG Global Brand Ambassador. In 2013 Norman made inquiries for investment opportunities, then followed through on procedure.

In a recent press release, Chua commented on twitter too, on a BBC story which reported a recent joint international study that credited ganoderma with weight loss. Chua pointed out that for years, ganoderma has been a staple of traditional Asian medicine. He added that it was gratifying to see the scientific community finally validating the benefits and properties of ganoderma.  Follow Bernie on Facebook to keep up with where the company goes forward from this point.

Comments are closed.